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Abstract
Purpose To gain insight into the patient characteristics of surgically treated hydrocephalus in the Netherlands, we report the first
data from the Dutch Quality Registry NeuroSurgery (QNRS) database for infants with hydrocephalus requiring surgical
intervention.
Methods We used the prospectively gathered database concerning infants ≤ 2 years of age surgically treated for hydrocephalus.
We report data from start of registry, concerning etiology, age, and treatment of patients registered. We compared data with the
Hydrocephalus Clinical Research Network (HCRN), a multicenter network of pediatric neurosurgical institutions in North
America.
Results A total of 359 operated infants was registered in the period from 2010 to 2017. A drop in patients registered was seen in
2015, possibly due to revisions of the database. Most infants were operated on between 1 and 6 months of age. Cause of
hydrocephalus was predominantly intracranial hemorrhage, followed by congenital causes. The proportion of infants with
aqueduct stenosis and myelomeningocele as cause of hydrocephalus stayed relatively stable during this period of registration.
Initial shunting was performed in 40% and reservoir/ETV as initial treatment was done in 60%. In both groups, 50% needed
revision surgery.
Conclusions The first data concerning surgically treated pediatric hydrocephalus from a prospectively collected Dutch register
are presented, showing similar results when comparing to the HCRN database.
Keywords Fetal cerebral ventriculomegalies . Hydrocephalus . Hydrocephalus congenital . Hydrocephalus etiology .
Neurosurgery . Pediatrics . Surgical procedures . Operative . Registries
Abbreviations
QNRS Dutch Quality Registry Neurosurgery
CSF Cerebrospinal fluid
HCRN Hydrocephalus Clinical Research Network
NVvN Dutch Society of Neurosurgery
MMC Myelomeningocele
ETV Endoscopic third ventriculostomy
Introduction
To elucidate the effectiveness of treatment and patient out-
come after neurosurgery several clinical registries have
emerged in Europe and North America [1–4]. These registries
have proven to be valuable tools to evaluate quality of care [4],
and may be a means to compare effectiveness between
methods and treatment centers.
The Dutch Society of Neurosurgery maintains a quality
registry for neurosurgical procedures carried out in the 19
neurosurgical clinics in the Netherlands, the Quality Registry
of Neurosurgery (QRNS). Four neurosurgical illnesses are
structurally registered: subarachnoid hemorrhage, glioblasto-
ma multiforme, pituitary adenoma, and hydrocephalus in
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children ≤ 2 years of age. Hydrocephalus in infants and young
children is only treated in the neurosurgical clinics of the eight
university hospitals. Shunt implantation, ventricular access
device implantation, and endoscopic third ventriculostomy
are registered.
In young infants, the incidence of hydrocephalus has been
estimated to range from 2.0 to 8.1 per 1000 live births [5–10].
This wide range in incidence is partly due to the variety of
definitions being used, either with or without surgical inter-
vention, with or without trauma, and partly because registra-
tion took place over different time-periods and in different
countries. A thorough investigation of the incidence of con-
genital hydrocephalus in four regions in Europe did not in-
clude details about etiology [5]. The epidemiology and inci-
dence of infantile hydrocephalus requiring surgical interven-
tion has not been systematically reported in the European
population, and details about shunting outcome have been
published from single centers only [11, 12].
Shunt dysfunction with subsequent shunt revisions are
common problems in infants. Most shunt dysfunctions occur
at a young age and decrease with age [13]. Systematically
obtained information about etiology and shunt dysfunction
might give insight into the process of shunt dysfunction in
young infants. A study of the Hydrocephalus Clinical
Research Network (HCRN), a multicenter network of pediat-
ric neurosurgical institutions in North America [14], com-
pared their clinical data registry to a historical cohort. They
reported a reduction in the risk for time to first shunt failure in
children until 19 years of age. A cause or relation with etiol-
ogy for this reduction could not be clearly identified, but was
hypothesized to be a combination of differences in diagnosis
of shunt failure, patient selection, baseline characteristics,
practice patterns, and interval to follow-up.
To elucidate the etiology of surgically treated infantile hy-
drocephalus in a Dutch population, we investigated the Dutch
QRNS database for infants with hydrocephalus requiring sur-
gical intervention. We report the first time-period of registra-
tion, from the years 2010–2017, in order to evaluate the reg-
istration implementation and to study possible shifts in surgi-
cal practice patterns. Also we compared our findings with the
cohorts studied in North America and Canada. We aim to
report etiology, age at intervention, and first treatment data
with prospectively gathered data. This will be the first presen-




The data we present is derived from the QRNS, the systematic
database of the Dutch Society of Neurosurgery (NVvN) in
collaboration with the Stichting Informatievoorziening Zorg
(SIVZ), a nationwide institute concerned with the registration
and data handling of healthcare institutes in the Netherlands.
In the QNRS database all patients treated for subarachnoid
hemorrhage, glioblastoma multiforme, pituitary adenoma,
and hydrocephalus in children under 2 years of age in the
Netherlands are registered, with details concerning diagnosis,
treatment and follow-up.We gathered the data of patients born
between 2010 and 2017 who were surgically treated for hy-
drocephalus within in the first 2 years of life. Date of diagno-
sis, as entered into the database, was used as date of registra-
tion. Data was collected for first intervention and revision, if
revision was necessary.
Patients were treated at 1 of 8 dedicated pediatric neurosur-
gical centers (Academic Medical Center Amsterdam, Leiden
University Medical Center; VU University Medical Center
Amsterdam; University Medical Center Utrecht; Maastricht
University Medical Center; Radboud University Medical
Center Nijmegen; Erasmus University Medical Center
Rotterdam; University Medical Center Groningen, the
Netherlands).
We report data from birth years 2010 through 2017.
Permission to use data was granted for each participating cen-
ter. Data were anonymized before analyses, and local ethical
research protocol for data collection was adhered to for the
QNRS.
We compared data concerning age at intervention and eti-
ology of hydrocephalus with the cohort published by the
Hydrocephalus Clinical Research Network (HCRN) [14]; a
multicenter network of 7 pediatric neurosurgical institutions
in North America. This cohort consists of prospectively col-
lected data of patients ≤ 19 years, surgically treated for hydro-
cephalus between 2008 and 2012. As follow-up of children
differed per center, it was assumed that the absence of follow-
up data means no shunt revision took place.
Definitions
Etiology of hydrocephalus was determined in the QRNS da-
tabase as either aqueductal stenosis, hemorrhage (due to pre-
maturity and other causes), cerebrospinal fluid infection (men-
ingitis/ventriculitis/encephalitis), tumor (all types),
myelomeningocele (MMC), congenital, miscellaneous, or un-
known. The miscellaneous group included intracranial cysts,
posterior fossa cysts, and craniosynostosis.
Statistics
We used Predictive Analytic Software (PASW) 18.0 for
Windows by SPSS (SPSS Inc., Chicago, IL) for data
analyses.
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Results
Population
From 2010 to 2017, 359 patients were registered for surgery
of hydrocephalus in the first 2 years of life. In 10 patients, data
on treatment was incomplete and kept out of analyses.
Registration showed an upward trend with a peak in 2013,
followed by a decrease for 2015 and 2016. Table 1 shows
patients characteristics of total and per year of registration.
Of the total 349 patients, more patients were male (53%), this
being consistent for each separate year of registration. As seen
in Fig. 1, hemorrhage was leading diagnosis for surgical treat-
ment in almost every year, followed by congenital hydroceph-
alus (resp. 42 and 22% in total group). The proportion of
infants with aqueduct stenosis and MMC as underlying cause
stayed stable over the years registered. In 2015 the proportion
of unknown etiology showed a sudden increase, being 25% of
total registered patients. For the years 2015 and 2016, tumor-
related hydrocephalus was not reported.
Most children were operated between 1 month after birth
and before they reached 6 months of age, a consistent finding
when looking at the separate years as well as in the total group
(Fig. 2).
In 136 (39% of total) patients, initial treatment was
Ommaya/Rickham reservoir placement, in 59 (17%), ETV
and 12 (3%) were categorized as other (temporary external
drains/serial lumbar punctures) (Fig. 3). In 141 (40%) patients,
a shunt was placed directly. In one patient, ventriculoperitoneal
shunt placement and ETVwere combined. Revision was need-
ed for 71 (52%) infants of the Ommaya/Rickham cohort, 28
(48%) in the ETV group, and 6 (50%) in the group of serial
punctures. Of the 141 shunts placed directly at diagnosis,
70(50%) needed revision, and 71 (50%) did not. The patient
treated with shunt and ETV simultaneously did not need revi-
sion. The specifics of the revisions performed were not includ-
ed in the database, so whether revisions being shunt insertion,
shunt explantation, or re-ETV is unknown.
Discussion
This paper reports the first data concerning pediatric hydro-
cephalus registered in the QRNS, the systematic database of
the Dutch Society of Neurosurgery (NVvN). With the impor-
tance of structural multicenter registration of surgical interven-
tion being shown in registries from the USA and Canada [14],
this is the first report from a prospectively collected nation-
wide European registry concerning pediatric hydrocephalus.
The number of registered patients shows a peak in 2013.
This peak might be due to the more structural use of the reg-
istry and the improved implementation of the database. It is
not likely that such in increase can be accounted to patient
increase alone, and it is known that the implementation and
widespread use of a registry will take some time [4]. The
decrease in patient numbers in the registry from 2014 onward
might be accounted to the introduction of a new improved
database format, causing a pause in data input.
Gender distribution among registered patients was identical
over the years, with male predominance. This is consistent
with previous reports, showing a larger proportion of male
pediatric hydrocephalic patients [15–17]. The reason for male
predominance in the hydrocephalic pediatric patient popula-
tion is still not accounted for, so far only a possible difference
in normal values of ventricle size between genders has been
described [18].
Table 1 Patient characteristics and annual distribution of the QNRS cohort of patients registered for surgical intervention of hydrocephalus under the
age of 2 years
Total 2010 2011 2012 2013 2014 2015 2016
Patients registered
(% of total)
349 4 (1) 38 (11) 51 (15) 89 (26) 85 (24) 56 (16) 22 (6)
Male/female (% of total) 186 (53)/139 (40) 3 (75)/1 (25) 23 (61)/15 (39) 28 (55)/23 (45) 48 (54)/40 (45) 51 (60)/34 (40) 24 (43)/18 (32) 8 (36)/5 (23)
Etiology (% of group)
Hemorrhage 145 (42) 1 (25) 12 (32) 18 (35) 37 (42) 38 (45) 29 (52) 10 (46)
Congenital 76 (22) 2 (50) 13 (34) 10 (20) 25 (28) 17 (20) 4 (7) 4 (18)
Myelomeningocele 32 (9) 1 (25) 4 (11) 4 (8) 7 (8) 6 (7) 8 (14) 2 (9)
Aquaduct stenosis 30 (9) 0 2 (5) 4 (8) 5 (6) 12 (14) 5 (9) 2 (9)
Tumor 22 (6) 0 4 (11) 4 (8) 6 (7) 5 (6) 0 0
Cerebrospinal fluid
infection
18 (5) 0 2 (5) 5 (10) 2 (2) 6 (7) 2 (4) 1 (5)
Miscellaneous 16 (5) 0 1 (3) 5 (10) 6 (7) 1 (1) 1 (2) 2 (9)
Unknown 10 (3) 0 0 1 (2) 1 (1) 0 7 (13) 1 (5)
Age at surgical intervention (% of group)
< 1st month 94 (27) 0 11 (29) 11 (22) 31 (35) 22 (26) 14 (25) 5 (23)
1 to < 6 months 152 (44) 4 (100) 18 (48) 24 (47) 35 (40) 42 (50) 22 (40) 7 (32)
6 to < 12 months 44 (13) 0 8 (21) 10 (20) 7 (8) 14 (17) 4 (7) 1 (5)
12–24 months 35(10) 0 1(3) 6(12) 15(17) 7(8) 2(4) 0
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The first intervention most often took place in children
aged ≤ 6 months (44%). In the group of the Hydrocephalus
Clinical Research Network Registry [14], the biggest propor-
tion of children operated on was also at age between 1 and
6 months. The overall percentage, 30%, was lower, but that
might be explained by the difference in inclusion criteria, be-
ing until age 19, in comparison with our group until 2 years of
age. Reason for this peak in age at operation might be the
underlying cause of the hydrocephalus, being mostly hemor-
rhage and congenital cause, together accounting for 64% of
the group. After hemorrhage, a posthemorrhagic ventricular
dilatation (PHVD) occurs mostly in preterm born babies, with
low birth weight. The subsequent hydrocephalus develops
over time and is in the Netherlands preferably initially treated
with serial lumbar punctures or serial punctures from a
ventricular access device (Ommaya/Rickham reservoir) [19].
This way, an infant is more likely to be > 1 month of age.
When looking at both causes of hydrocephalus separately,
the largest percentage of children with hemorrhage (49%)
and congenital causes (46%) was operated on in the period
between 1 and 6 months of age.
The percentage of infants who needed surgical intervention
due to aqueduct stenosis (9% of total) stayed more or less
stable over the years of registration. Aqueduct stenosis repre-
sented 8% in the American/Canadian group. The incidence of
aqueduct stenosis shows a consistency in the Western world
[20, 21].
Compared with the Dutch database, a larger percentage of
MMCwas reported in the HCRN database (9% vs 16%). This





















Fig. 1 Proportions of the
etiologies of surgically intervened
hydrocephalus for total and

















Fig. 2 Distribution of age at first
intervention
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pregnancies for MMC in the Netherlands in comparison to the
HCRN cohort [18], due to the introduction of the structural
prenatal ultrasound offered to all pregnant women in the
Netherlands since 2007. In the HCRN database, the incidence
of MMWas etiology showed a decrease when compared with
a historical cohort, possibly due to the introduction of food
fortification with folic acid [22].
The sudden decrease of tumor-based hydrocephalus might
be caused by the reformatting of the database in this period in
combination with a centralization of pediatric oncological care
in the Netherlands. The difference in tumor as underlying
cause of hydrocephalus between the Dutch and HCRN data-
base (6% versus 18%) is most likely explained by the differ-
ences in ages included in the databases [23]. The proportion of
CSF infection as a cause for surgery is approximately the same
in both groups.
The collected data concerning treatment method showed
that in 141 infants (40% of total group) a shunt was placed
directly. In this group, there was a 50% chance for the need of
revision. Of the remaining 207 infants (60%, not taking into
account 1 infant with shunt and ETV combined), 105 (51%)
needed revision. In all treatment groups, the chance of revi-
sion was about 50%. The specifics of the revisions performed
were not included in the database, so whether revisions being
shunt insertion, shunt explantation, or re-ETV are unknown.
Studies into survival rates have shown better ETV survival in
young infants (< 6 months of age) with aquaduct stenosis, and
worse survival rates in children with MMC, hemorrhage or
infection, and different success rates of re-ETVor shunt place-
ment [24–26]. These data, not included in our study, should be
reported in future studies to compare success rate of surgery
and outcome data of our surgical experience with other data-
bases [19, 24].
When looking at our results, the limitations of our study
should be taken into account. Due to the new implementation
of the database, start-up problems causing incomplete data are
widespread. The separate centers handled registration differ-
ently, and the database was revised more than once, causing
gaps in data entry. For the purpose of this analysis, it was
assumed that the absence of follow-up data means no shunt
revision took place. In the Netherlands, shunt surgery in chil-
dren only takes place in 8 university hospitals; therefore, it is
highly unlikely that revisions were not entered into the data-
base. But even though the limitations of the study, the useful-
ness of a database concerning surgically treated hydrocepha-
lus, also for future study, has been presented.
Conclusion
We present the first prospectively collected multicenter data of
a European based national registry for surgically intervened
pediatric hydrocephalus in the first 2 years of life, over the
period 2010–2017. Our data show that most infants are surgi-
cally treated for hydrocephalus are between 1 and 6 months of
age, and concerning the etiology the proportion of post-
hemorrhagic and congenital causes are most frequently seen.
In 40% of infants, treatment was initial shunt placement, ver-
sus 60% of infants treated with reservoir, ETV or taps.
Revision percentage was 50% for each treatment method.
Our findings concerning etiology and age at treatment show
similarity when compared with a large North American
registry.
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